| abstract |
Described herein are compounds and pharmaceutical compositions containing such compounds, which mondulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FALP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases. |